Director at 908 Devices (NASDAQ: MASS) sells 20,000 shares under 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
908 Devices Inc. director Christopher D. Brown sold shares of company stock. On this Form 4, he reported an open-market sale of 20,000 shares of common stock at a weighted average price of $8.73 per share. After the transaction, he directly holds 875,559 shares. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 24, 2025.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 20,000 shares ($174,600)
Net Sell
1 txn
Insider
Brown Christopher D.
Role
null
Sold
20,000 shs ($175K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 20,000 | $8.73 | $175K |
Holdings After Transaction:
Common Stock — 875,559 shares (Direct, null)
Footnotes (1)
- This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.61 to $8.86 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Shares sold: 20,000 shares
Weighted average sale price: $8.73 per share
Shares held after transaction: 875,559 shares
+1 more
4 metrics
Shares sold
20,000 shares
Open-market sale of common stock on June 3, 2026
Weighted average sale price
$8.73 per share
Multiple transactions between $8.61 and $8.86
Shares held after transaction
875,559 shares
Direct ownership following reported sale
Net buy/sell direction
Net sale of 20,000 shares
transactionSummary netBuySellShares and direction
Key Terms
Rule 10b5-1 trading plan, weighted average price, open-market sale, Form 4
4 terms
Rule 10b5-1 trading plan regulatory
"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2025."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
open-market sale financial
"transaction_action: "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
What insider transaction did 908 Devices (MASS) director Christopher D. Brown report?
Christopher D. Brown reported selling 20,000 shares of 908 Devices common stock in an open-market transaction. The Form 4 shows this as a sale of non-derivative common shares, reducing but not eliminating his direct equity position in the company.
Was the 908 Devices (MASS) insider sale under a Rule 10b5-1 trading plan?
Yes. A footnote states the transaction was made pursuant to a Rule 10b5-1 trading plan adopted on November 24, 2025. Such plans pre-schedule trades, indicating this sale was part of a pre-arranged program rather than a discretionary, opportunistic market decision.
What does the price range in Christopher D. Brown’s 908 Devices (MASS) sale mean?
The filing notes the $8.73 figure is a weighted average across multiple trades. Shares were sold in separate transactions between $8.61 and $8.86, and Brown has committed to provide detailed breakdowns of shares sold at each price upon request to specified parties.
Does this 908 Devices (MASS) Form 4 include any option exercises or derivative transactions?
No derivative transactions are listed in the summary. The Form 4 data show one non-derivative open-market sale of common stock and a derivativeSummary with no remaining derivative positions reported in this particular filing excerpt.